Transcriptional activation of the cholecystokinin gene by DJ-1 through Interaction of DJ-1 with RREB1 and the effect of DJ-1 on the cholecystokinin level in mice

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Yamane, Takuya ^a   Suzui, Sayaka ^a   Kitaura, Hirotake ^a   Takahashi Niki, Kazuko ^a   Iguchi Ariga, Sanae M M ^a   Ariga, Hiroyoshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CHOLECYSTOKININ; DJ 1 PROTEIN; DOPAMINE; MESSENGER RNA; RAS RESPONSIVE ELEMENT BINDING PROTEIN 1; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; CHOLECYSTOKININ BLOOD LEVEL; CHOLECYSTOKININ GENE; CONTROLLED STUDY; DOPAMINE RELEASE; GALLBLADDER CONTRACTION; GENE ACTIVATION; GENE ACTIVITY; GENE EXPRESSION; GENE TARGETING; HORMONE ACTION; HORMONE SYNTHESIS; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN BINDING; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SUBSTANTIA NIGRA; TRANSCRIPTION INITIATION;

ANIMALS; CHOLECYSTOKININ; CHROMATIN IMMUNOPRECIPITATION; DNA-BINDING PROTEINS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; MICE; MICE, KNOCKOUT; NIH 3T3 CELLS; ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84892424691     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078374     Document Type: Article

References (35)

1. Nagakubo D, Taira T, Kitaura H, Ikeda M, Tamai K, et al. (1997) DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. Biochem Biophys Res Commun 231: 509-513.
2. Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, et al. (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299: 256-259.
3. Kahle PJ, Waak J, Gasser T (2009) DJ-1 and prevention of oxidative stress in Parkinson's disease and other age-related disorders. Free Radic Biol Med 47: 1354-1361.
4. Wilson MA (2011) The role of cysteine oxidation in DJ-1 function and dysfunction. Antioxid Redox Signal 15: 111-122.
5. Ariga H, Takahashi-Niki K, Kato I, Maita H, Niki T, et al. (2013) Neuroprotective function of DJ-1 in Parkinson's disease. Oxid Med Cell Longev 2013: 683920.
6. Takahashi K, Taira T, Niki T, Seino C, Iguchi-Ariga SMM, et al. (2001) DJ-1 positively regulates the androgen receptor by impairing the binding of PIASx alpha to the receptor. J Biol Chem 276: 37556-37563.
7. Niki T, Takahashi-Niki K, Taira T, Iguchi-Ariga SMM, Ariga H (2003) DJBP: a novel DJ-1-binding protein, negatively regulates the androgen receptor by recruiting histone deacetylase complex, and DJ-1 antagonizes this inhibition by abrogation of this complex. Mol Cancer Res 1: 247-261.
8. Shinbo Y, Taira T, Niki T, Iguchi-Ariga SMM, Ariga H (2005) DJ-1 restores p53 transcription activity inhibited by Topors/p53BP3. Int J Oncol 26: 641-648.
9. Zhong N, Kim CY, Rizzu P, Geula C, Porter DR, et al. (2006) DJ-1 transcriptionally up-regulates the human tyrosine hydroxylase by inhibiting the sumoylation of pyrimidine tract-binding protein-associated splicing factor. J Biol Chem 281: 20940-20948.
10. Clements CM, McNally RS, Conti BJ, Mak TW, Ting JP (2006) DJ-1, a cancerand Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc Natl Acad Sci USA 103: 15091-15096.
11. Tillman JE, Yuan J, Gu G, Fazli L, Ghosh R, et al. (2007) DJ-1 binds androgen receptor directly and mediates its activity in hormonally treated prostate cancer cells. Cancer Res 67: 4630-4637.
12. Ishikawa S, Taira T, Niki T, Takahashi-Niki K, Maita C, et al. (2009) Oxidative status of DJ-1-dependent activation of dopamine synthesis through interaction of tyrosine hydroxylase and 4-dihydroxy-L-phenylalanine (L-DOPA) decarboxylase with DJ-1. J Biol Chem 284: 28832-28844.
13. Fan J, Ren H, Jia N, Fei E, Zhou T, et al. (2008) DJ-1 decreases Bax expression through repressing p53 transcriptional activity. J Biol Chem 283: 4022-4030.
14. Xu J, Zhong N, Wang H, Elias JE, Kim CY, et al. (2005) The Parkinson's disease-associated DJ-1 protein is a transcriptional co-activator that protects against neuronal apoptosis. Hum Mol Genet 14: 1231-1241.
15. Kato I, Maita H, Takahashi-Niki K, Saito Y, Noguchi N, et al. (2013) Oxidized DJ-1 inhibits p53 by sequestering p53 from promoters in a DNA-binding affinity-dependent manner. Mol Cell Biol 33: 340-359.
16. Yamaguchi S, Yamane T, Takahashi-Niki K, Kato I, Niki T, et al. (2012) Transcriptional activation of low-density lipoprotein receptor gene by DJ-1 and effect of DJ-1 on cholesterol homeostasis. PLoS One 7: e38144.
17. Nishinaga H, Takahashi-Niki K, Taira T, Andreadis A, Iguchi-Ariga SM, et al. (2005) Expression profiles of genes in DJ-1-knockdown and L 166 P DJ-1 mutant cells. Neurosci Lett 390: 54-59.
18. Pietrowsky R, Specht G, Fehm HL, Born J (1994) Comparison of satiating effects of ceruletide and food intake using behavioral and electrophysiological indicators of memory. Int J Psychophysiol 17: 79-89.
19. Schreiber H, Stolz-Born G, Pietrowsky R, Kornhuber HH, Fehm HL, et al. (1995) Improved event-related potential signs of selective attention after the administration of the cholecystokinin analog ceruletide in healthy persons. Biol Psychiatry 37: 702-712.
20. Seroogy KB, Dangaran K, Lim S, Haycock JW, Fallon JH (1989) Ventral mesencephalic neurons containing both cholecystokinin- and tyrosine hydroxylase-like immunoreactivities project to forebrain regions. J Comp Neurol 279: 397-414.
21. Freeman AS, Chiodo LA, Lentz SI, Wade K, Bannon MJ (1991) Release of cholecystokinin from rat midbrain slices and modulatory effect of D2DA receptor stimulation. Brain Res 555: 281-287.
22. Skirboll LR, Grace AA, Hommer DW, Rehfeld J, Goldstein M, et al. (1981) Peptide-monoamine coexistence: studies of the actions of cholecystokinin-like peptide on the electrical activity of midbrain dopamine neurons. Neuroscience 6: 2111-2124.
23. Hommer DW, Skirboll LR (1983) Cholecystokinin-like peptides potentiate apomorphine-induced inhibition of dopamine neurons. Eur J Pharmacol 91: 151-152.
24. Takahashi-Niki K, Niki T, Taira T, Iguchi-Ariga SMM, Ariga H (2004) Reduced anti-oxidative stress activities of DJ-1 mutants found in Parkinson's disease patients. Biochem Biophys Res Commun 320: 389-397.
25. Miyazaki S, Yanagida T, Nunome K, Ishikawa S, Inden M, et al. (2008) DJ-1-binding compounds prevent oxidative stress-induced cell death and movement defect in Parkinson's disease model rats. J Neurochem 105: 2418-2434.
26. Yoshida T, Kitaura H, Hagio Y, Sato T, Iguchi-Ariga SMM, et al. (2008) Negative regulation of the Wnt signal by MM-1 through inhibiting expression of the wnt4 gene. Exp Cell Res 314: 1217-1228.
27. Ebihara M, Ohba H, Hattori E, Yamada K, Yoshikawa T (2003) Transcriptional activities of cholecystokinin promoter haplotypes and their relevance to panic disorder susceptibility. Am J Med Genet B Neuropsychiatr Genet 118B: 32-35.
28. Thiagalingam A, De Bustros A, Borges M, Jasti R, Compton D, et al. (1996) RREB-1, a novel zinc finger protein, is involved in the differentiation response to Ras in human medullary thyroid carcinomas. Mol Cell Biol 16: 5335-5345.
29. Zhang S, Qian X, Redman C, Bliskovski V, Ramsay ES, et al. (2003) p16 INK4a gene promoter variation and differential binding of a repressor, the ras-responsive zinc-finger transcription factor, RREB. Oncogene 22: 2285-2295.
30. Mukhopadhyay NK, Ferdinand AS, Mukhopadhyay L, Cinar B, Lutchman M, et al. (2006) Unraveling androgen receptor interactomes by an array-based method: discovery of proto-oncoprotein c-Rel as a negative regulator of androgen receptor. Exp Cell Res 312: 3782-3795.
31. Chen RL, Chou YC, Lan YJ, Huang TS, Shen CK (2010) Developmental silencing of human zeta-globin gene expression is mediated by the transcriptional repressor RREB1. J Biol Chem 285: 10189-10197.
32. Mukhopadhyay NK, Cinar B, Mukhopadhyay L, Lutchman M, Ferdinand AS, et al. (2007) The zinc finger protein ras-responsive element binding protein-1 is a coregulator of the androgen receptor: implications for the role of the Ras pathway in enhancing androgenic signaling in prostate cancer. Mol Endocrinol 21: 2056-2070.
33. Lev N, Ickowicz D, Barhum Y, Lev S, Melamed E, et al. (2009) DJ-1 protects against dopamine toxicity. J Neural Transm 116: 151-160.
34. Ishikawa S, Taira T, Takahashi-Niki K, Niki T, Ariga H, et al. (2010) Human DJ-1-specific transcriptional activation of tyrosine hydroxylase gene. J Biol Chem 285: 39718-39731.
35. Ishikawa S, Tanaka Y, Takahashi-Niki K, Niki T, Ariga H, et al. (2012) Stimulation of vesicular monoamine transporter 2 activity by DJ-1 in SH-SY5Y cells. Biochem Biophys Res Commun 421: 813-818.